MacTel 2型安慰剂组阅读速度分析:BCVA稳定时仍见下降
该二次分析纳入两项 revakinagene taroretcel-lwey 治疗 MacTel 的3期试验中111只安慰剂治疗眼(104只有完整数据),评估24个月内BCVA与阅读速度的关系。
要点
- BCVA每损失1个字母,阅读速度下降2.1 wpm(P<0.0001)。
- 控制基线因素后,第24个月左眼阅读速度预计比右眼慢约18.5 wpm。
核心结论
- BCVA可能无法完整反映MacTel进展中的功能性视力丧失,阅读速度在BCVA稳定时仍可检测到下降。
- 阅读速度敏感且具临床相关性,可作为评估MacTel进展和治疗疗效的有意义终点,并帮助临床量化功能性视力丧失。
研究设计与样本
- 两项 revakinagene taroretcel-lwey 治疗MacTel的3期临床试验中安慰剂治疗组的二次分析。
- 共111只安慰剂治疗眼入组,其中104只有完整数据用于分析。
- 评估24个月内阅读速度(国际阅读速度测试,wpm/眼)和BCVA(ETDRS字母)。
- 采用多元线性回归分析BCVA丧失与阅读速度下降的关联,并用协方差分析(ANCOVA)评估眼别对阅读速度的影响。
主要发现
- BCVA每损失1个字母,阅读速度下降2.1 wpm(P<0.0001)。
- 控制基线因素的ANCOVA显示,第24个月左眼阅读速度预计比右眼慢约18.5 wpm。
临床怎么用
- 在MacTel随访中,除BCVA外应关注阅读速度,以更全面评估功能性视力变化。
- 阅读速度可作为临床试验中评估MacTel进展和治疗疗效的敏感终点。
- 临床中可用阅读速度量化患者的功能性视力丧失,尤其当BCVA看似稳定时。
局限性
- 本文为安慰剂治疗组的二次分析,结果外推需谨慎。
- 仅纳入111只眼且104只有完整数据,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the relationship between best-corrected visual acuity (BCVA) and reading speed in the sham-treated cohorts from two Phase 3 clinical trials of revakinagene taroretcel-lwey for macular telangiectasia type 2 (MacTel) and to determine whether reading speed captures functional decline not reflected by changes in BCVA. METHODS: This secondary analysis evaluated reading speed (words per minute [wpm] per eye using the International Reading Speed Test) and BCVA (Early Treatment Diabetic Retinopathy Study letters) over 24 months. Associations between BCVA loss and reading speed decline were examined using multiple linear regression. Analysis of covariance (ANCOVA) assessed the effect of eye laterality on reading speed, controlling for baseline factors. RESULTS: Of 111 enrolled sham-treated eyes, 104 had complete data for analysis. For every 1-letter loss of BCVA, the reading speed decreased by 2.1 wpm (P < 0.0001). Sixty-eight eyes maintained stable BCVA (change of <5 letters) but experienced a statistically significant reading speed decline of 19.4 wpm over 24 months (P < 0.0001). An ANCOVA controlling for baseline factors revealed that left eyes were predicted to read approximately 18.5 wpm slower than right eyes at Month 24. CONCLUSION: These findings suggest that BCVA may incompletely capture progressive functional vision loss in MacTel, whereas reading speed detected decline even when BCVA remained stable. Given its sensitivity and clinical relevance, reading speed may provide a meaningful endpoint for assessing MacTel progression and therapeutic efficacy and may also help clinicians quantify functional vision loss in routine practice.
引用
- Eliott D, Hatcher KA, Delgiodice MJ, et al. READING SPEED IN MACULAR TELANGIECTASIA TYPE 2: AN ANALYSIS OF SHAM PATIENTS IN THE REVAKINAGENE TARORETCEL-LWEY (NT-501) PHASE 3 TRIALS. Retina. 2026. PMID: 42961160. doi:10.1097/IAE.0000000000005045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。